NARI's logo.
Ticker Symbol: NARI

Inari Medical Inc

$90.10 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001531048

Company Profile

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
CEO: N/A
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $65.80
Change: -$0.41 ( -0.62%)
Days Range: $65.15 - $66.70
Beta: 0.99
52wk. High: $83.84
52wk. Low: $52.59
Ytd. Change 3.55%
50 Day Moving Average: $64.19
200 Day Moving Average: $62.89
Shares Outstanding: 57352371

Valuation

Market Cap: 377.4B
PE Ratio: -225.50
EPS (TTM): -0.2918

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A